Skip to main content

A "Trojan horse"to fight against brain cancer

Images

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

 

The newspaper “El Periódico de Catalunya” devotes a page to a project between IRB Barcelona and the VHIO. This project seeks to develop a new strategy against brain tumours; this approach is based on the use of peptide shuttle that can cross the blood-brain barrier to reach the tumour. Ernest Giralt and Meritxell Teixidó are the IRB Barcelona researchers involved.

Link to the feature article (PDF in Catalan; (PDF in Spanish)

El Periódico de Catalunya online

Link to the IRB Barcelona news on the project

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).